GlassScriptPhysician profile
Emily Stonerock
NPI 1134337173
$7,839.73
in general payments reported to CMS, 2019-2025
18 companies · $34.71 in 2025
The $34.71 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $11.82 · 2021: $12.86 · 2022: $6,909 · 2023: $114 · 2024: $385 · 2025: $34.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.75 |
| Education | $106.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,027.27 | 2022-2024 | Da Vinci Surgical System |
| Optumhealth Care Solutions, LLC | $160.98 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Genentech USA, INC. | $132.00 | 2024 | Evrysdi |
| Pfizer INC. | $122.10 | 2019-2023 | |
| Abbvie INC. | $108.15 | 2019 | |
| Duchesnay USA Incorporated | $48.28 | 2019 | |
| Novo Nordisk INC | $34.18 | 2022-2025 | Wegovy |
| Exeltis, USA INC. | $31.12 | 2022-2023 | Slynd |
| Amgen INC. | $29.02 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.93 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.77 | 2019 | |
| Daiichi Sankyo INC. | $16.00 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.79 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.29 | 2019 | |
| Merck Sharp & Dohme LLC | $14.32 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $13.29 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.39 | 2022 | |
| Therapeuticsmd, INC. | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Stonerock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.